Method for diagnosing pulmonary artery hypertension

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8609356
APP PUB NO 20110033876A1
SERIAL NO

12936745

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to an in vitro method for detecting pulmonary arterial hypertension (PAHT), or the risk of developing PAHT, which includes determining the presence and/or amount of anti-tenascin C antibodies in a biological sample from a patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS75004 PARIS
UNIVERSITE PARIS DESCARTES12 RUE DE L'ECOLE DE MÉDECINE PARIS 75006
UNIVERSITE PARIS - SUD 1115 RUE GEORGES CLEMENCEAU ORSAY CEDEX F-91405

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Humbert, Marc Issy les Moulineaux, FR 10 12
Mouthon, Luc Saint Mandé, FR 4 13
Tamby, Mathieu Aulnay sous Bois, FR 1 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 17, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00